1. Home
  2. NL vs TLSI Comparison

NL vs TLSI Comparison

Compare NL & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NL Industries Inc.

NL

NL Industries Inc.

N/A

Current Price

$6.89

Market Cap

283.1M

Sector

Industrials

ML Signal

N/A

Logo TriSalus Life Sciences Inc.

TLSI

TriSalus Life Sciences Inc.

N/A

Current Price

$5.14

Market Cap

270.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NL
TLSI
Founded
1891
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
283.1M
270.2M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
NL
TLSI
Price
$6.89
$5.14
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
41.0K
165.2K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
10.22%
N/A
EPS Growth
N/A
N/A
EPS
0.27
N/A
Revenue
$158,285,000.00
$45,151,000.00
Revenue This Year
$9.32
$35.45
Revenue Next Year
N/A
$37.58
P/E Ratio
$25.00
N/A
Revenue Growth
8.46
53.41
52 Week Low
$5.04
$2.20
52 Week High
$8.60
$7.95

Technical Indicators

Market Signals
Indicator
NL
TLSI
Relative Strength Index (RSI) 64.35 56.23
Support Level $5.67 $4.21
Resistance Level $8.60 $5.58
Average True Range (ATR) 0.21 0.27
MACD 0.02 -0.05
Stochastic Oscillator 77.11 57.47

Price Performance

Historical Comparison
NL
TLSI

About NL NL Industries Inc.

NLI Holdings Inc, formerly known as NL Industries Inc, is a holding company that operates in the component products industry. Through its subsidiary, it manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. It also produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors. The company developed Pressure-Enabled Drug Delivery (PEDD) to overcome high intratumoral pressure and off-target delivery. Its 510(k) cleared device, the TriNav Infusion System using PEDD technology, is used for interventional radiology procedures including transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or liver metastases. It has one reportable segment and generates revenue from sales of PEDD infusion systems, principally related to TriNav.

Share on Social Networks: